??????? ??? ?????????????, ????????????
2 ??????? 2564
/PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (???????????????? Gan & Lee ???????????: 603087.SH) ??????????????????????? 1 ?????????????????? ? ?????????????????????? American Diabetes Association ???????? 81 ????????????? 25-29 ??.?. ??????????????????????????????????????????????????????????????????????????? ?????? ???????? Aspart (GL-ASP), ???????? Lispro (GL-LIS) ??? ???????? Glargine (GL-GLA) ????? Profil (???????) ????????????????????????????????????
?????????????????????????????????????????????????????????????????????????? (PK) ???????????????? (PD) ??????????????????????????????? ????????????? Gan & Lee ???? ???????????????? PK ??? PD ?????????????????????????????????????????? ????????? ???????????????????????????????????????????????????????????????????????? [1,2,3]
???????????????????????????????????????????? ????????????????????????????????????????????????????????????? Gan & Lee ???????? 2564 ????????????????? 100 ????????????????????? ?????????????????????????????????????????????????????????? ??? Jia Lu ???????????????? Clinical Sciences ???????? "??????????????????????????????????????????????????????????????????????????????????????????? ?????????????????????????????????????????" ??????? ?????????????????????????????????????????????????????????????? Diabetes ® ?????????????????????????????????????????????????? GL-ASP, GL-LIS ??? GL-GLA ?????? 738-P, 736-P ??? 740-P ????????
????????? Gan & Lee
Gan & Lee ?????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????????? (recombinant insulin analog) 5 ??????????????? ?????? ??????????????? glargine injection (Basalin(R)), ???????????????? lispro injection (Prandilin(R)), ???????????????? aspart injection (Rapilin(TM)), ????????????????????????????? lispro injection (25R) (Prandilin(R)25) ??????? aspart 30 injection (Rapilin(TM)30) ???????????????????????????????????????? (GanleePen(TM)) ???????????????????????????????????????? (Ganlee Fine(TM))
??????? Gan & Lee ???????????????????????????????????????????????????????????????? ???????????????????????? Gan & Lee ????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????? ?????????????????? ???????????????????????? ???????????????????????????????????????? [email protected]
????????????:
1. Leona Plum- Mörschel, et. al. Proposed biosimilar insulin aspart (GL-ASP) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin aspart. June 22, 2021.
2. Eric Zijlstra, et. al. Proposed biosimilar insulin lispro (GL-LIS) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin lispro. June 22, 2021.
3. Tim Heise, et. al. Proposed biosimilar insulin glargine (GL-GLA) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin glargine. June 22, 2021.
??????: Gina Antonucci, 888-288-5395, [email protected]
